The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.83 CNY | +1.02% | -3.78% | -0.49% |
05-07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
05-07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.49% | 2.04B | |
+32.36% | 694B | |
+29.78% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.42% | 239B | |
-3.56% | 209B | |
+10.12% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.